المؤلفون: Michels, S, Nogova, L, Deschler-Baier, B, Sebastian, M, Schuler, M, Wermke, M, Felip, E, Rodriguez-Abreu, D, Rosell, R, Abdulla, DSY, Fischer, RN, Koleczko, S, Kron, A, Pinto, A, Riedel, R, Scheffler, M, Suptitz, J, Fassunke, J, Merkelbach-Bruse, S, Hellmich, M, Buttner, R, Wolf, J

المصدر: Oncology Research and Treatment
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::be0f3e41924e65d9109c2dabd6ab782d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4086

المؤلفون: Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany norbert.galldiks@uk-koeln.de.; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany., Abdulla DSY; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Lung Cancer Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Scheffler M; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Lung Cancer Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Wolpert F; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Werner JM; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Hüllner M; Department of Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland., Stoffels G; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany., Schweinsberg V; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Schlaak M; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Kreuzberg N; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Landsberg J; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Dermatology, University Hospital Bonn, Bonn, Germany., Lohmann P; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.; Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Ceccon G; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Baues C; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Radiation Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Trommer M; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Radiation Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Celik E; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Ruge MI; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Kocher M; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.; Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Marnitz S; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Radiation Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Fink GR; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany., Tonn JC; Department of Neurosurgery, University Hospital LMU Munich, Munich, Germany; and., Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Langen KJ; Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.; Department of Nuclear Medicine, RWTH University Hospital Aachen, Aachen, Germany., Wolf J; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Lung Cancer Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Mauch C; Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.; Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Apr; Vol. 62 (4), pp. 464-470. Date of Electronic Publication: 2020 Sep 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy*, Brain Neoplasms/*secondary , Brain Neoplasms/*therapy , Lung Neoplasms/*pathology , Melanoma/*pathology , Tyrosine/*analogs & derivatives, Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/diagnostic imaging ; Combined Modality Therapy ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Molecular Targeted Therapy ; Retrospective Studies ; Treatment Outcome

المؤلفون: Kron A; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Scheffler M; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Heydt C; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Ruge L; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Schaepers C; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Eisert AK; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Merkelbach-Bruse S; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Riedel R; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Nogova L; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Fischer RN; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Michels S; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Abdulla DSY; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Koleczko S; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Fassunke J; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Schultheis AM; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Kron F; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany; FOM University of Applied Sciences, Essen, Germany., Ueckeroth F; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Wessling G; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Sueptitz J; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Beckers F; Network Genomic Medicine, Cologne, Germany; Department of Thoracic Surgery, St. Vinzenz-Hospital Cologne, Cologne, Germany., Braess J; Network Genomic Medicine, Cologne, Germany; Department of Hematology and Oncology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany., Panse J; Network Genomic Medicine, Cologne, Germany; Department of Internal Medicine IV, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital RWTH Aachen, Aachen, Germany., Grohé C; Network Genomic Medicine, Cologne, Germany; Department of Pneumology, Evangelische Lungenklinik Berlin, Berlin, Germany., Hamm M; Network Genomic Medicine, Cologne, Germany; Department of Pneumology and Respiratory Medicine, Helios Medical Center of Hildesheim, Hildesheim, Germany., Kabitz HJ; Network Genomic Medicine, Cologne, Germany; Department of Internal Medicine II, Clinic of Konstanz, Konstanz, Germany., Kambartel K; Network Genomic Medicine, Cologne, Germany; Department of Thoracic Oncology and Interventional Bronchology, Hospital Bethanien Moers, Moers, Germany., Kaminsky B; Network Genomic Medicine, Cologne, Germany; Department of Pneumonology and Allergology, Hospital Bethanien Solingen, Solingen, Germany., Krueger S; Network Genomic Medicine, Cologne, Germany; Department of Pneumonology, Florence-Nightingale Hospital Düsseldorf, Düsseldorf, Germany., Schulte C; Network Genomic Medicine, Cologne, Germany; Joint Private Practice for Hematology/Oncology, Dortmund, Germany., Lorenz J; Network Genomic Medicine, Cologne, Germany; Department of Pneumology, Hospital Luedenscheid, Luedenscheid, Germany., Lorenzen J; Network Genomic Medicine, Cologne, Germany; Department of Pathology, Hospital Dortmund, Dortmund, Germany., Meister W; Network Genomic Medicine, Cologne, Germany; Department of Thoracic Oncology and Interventional Bronchology, Helios Medical Center of Hildesheim, Hildesheim, Germany., Meyer A; Network Genomic Medicine, Cologne, Germany; Department of Pulmonary Medicine, Maria Hilf Hospital GmbH, Moenchengladbach, Germany., Kappes J; Network Genomic Medicine, Cologne, Germany; Department of Internal Medicine and Pneumology, Catholic Hospital Koblenz, Koblenz, Germany., Reinmuth N; Network Genomic Medicine, Cologne, Germany; Department of Oncology, Asklepios Clinic Munich-Gauting, Munich-Gauting, Germany., Schaaf B; Network Genomic Medicine, Cologne, Germany; Department of Respiratory Medicine and Infectious Diseases, Medical Center North of Dortmund, Dortmund, Germany., Schulte W; Network Genomic Medicine, Cologne, Germany; Department of Pneumology and Allergology, GFO Clinic Bonn, Bonn, Germany., Serke M; Network Genomic Medicine, Cologne, Germany; Department of Pneumology and Oncology, Evangelic Hospital Hamm, Hamm, Germany., Buettner R; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany., Wolf J; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2021 Apr; Vol. 16 (4), pp. 572-582. Date of Electronic Publication: 2020 Dec 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Genetic Heterogeneity ; Humans ; Immunotherapy ; In Situ Hybridization, Fluorescence ; Mutation ; Proto-Oncogene Proteins c-met/genetics

المؤلفون: Rink S; Department of Prosthetic Dentistry, School of Dental and Oral Medicine, University of Cologne, Cologne, Germany., Manthou ME; Department of Histology and Embryology, School of Medicine, Faculty of Health Sciences, Aristotle University Thessaloniki, Thessaloniki, Greece., Arnold J; Department of Anatomy I, University of Cologne, Cologne, Germany., Grigo M; Department of Anatomy I, University of Cologne, Cologne, Germany., Dicken P; Department of Anatomy I, University of Cologne, Cologne, Germany., Abdulla DSY; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, University of Cologne, Cologne, Germany., Bendella H; Department of Neurosurgery, University of Witten/Herdecke, Cologne Merheim Medical Center (CMMC), Cologne, Germany., Nohroudi K; Department of Anatomy I, University of Cologne, Cologne, Germany., Angelov DN; Department of Anatomy I, University of Cologne, Cologne, Germany.

المصدر: Restorative neurology and neuroscience [Restor Neurol Neurosci] 2021; Vol. 39 (2), pp. 85-100.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9005499 Publication Model: Print Cited Medium: Internet ISSN: 1878-3627 (Electronic) Linking ISSN: 09226028 NLM ISO Abbreviation: Restor Neurol Neurosci Subsets: MEDLINE

مواضيع طبية MeSH: Spinal Cord Compression* , Spinal Cord Injuries*/complications , Spinal Cord Injuries*/drug therapy, Animals ; Erythropoietin ; Physical Therapy Modalities ; Rats ; Recovery of Function ; Vibration

المؤلفون: Nogova L; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Mattonet C; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany.; Onkologische Praxis Moers, Moers, Germany., Scheffler M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Taubert M; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany., Gardizi M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Sos ML; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Michels S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Fischer RN; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Limburg M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Abdulla DSY; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany., Persigehl T; Faculty of Medicine and University Hospital Cologne, Institute for Diagnostics und Intervention Radiology, University of Cologne, Cologne, Germany., Kobe C; Faculty of Medicine and University Hospital Cologne, Department for Nuclear Medicine, University of Cologne, Cologne, Germany., Merkelbach-Bruse S; Faculty of Medicine and University Hospital Cologne, Institute for Pathology, University of Cologne, Cologne, Germany., Franklin J; Faculty of Medicine, Institute for Medical Statistics and Bioinformatics, University of Cologne, Cologne, Germany., Backes H; Max Planck Institute for Metabolism Research, Cologne, Germany., Schnell R; Praxis for Medical Oncology and Haematology (PIOH), Frechen, Germany., Behringer D; Heamatology and Oncology, Augusta Hospital, Bochum, Germany., Kaminsky B; Bethanien Hospital, Solingen, Germany., Eichstaedt M; Medical Oncology and Haematology, St. Marien Hospital, Düren, Germany., Stelzer C; Institute for Biomedical and Pharmaceutical Research (IBMP), Nürnberg, Germany., Kinzig M; Institute for Biomedical and Pharmaceutical Research (IBMP), Nürnberg, Germany., Sörgel F; Institute for Biomedical and Pharmaceutical Research (IBMP), Nürnberg, Germany., Tian Y; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany.; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China., Junge L; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany., Suleiman AA; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany., Frechen S; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany., Rokitta D; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany., Ouyang D; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.; Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples, Changsha, China., Fuhr U; Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany., Buettner R; Faculty of Medicine and University Hospital Cologne, Institute for Pathology, University of Cologne, Cologne, Germany., Wolf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group, University of Cologne, Cologne, Germany.

المصدر: Cancer medicine [Cancer Med] 2020 Jul; Vol. 9 (14), pp. 4991-5007. Date of Electronic Publication: 2020 May 21.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Everolimus/*therapeutic use , Fluorodeoxyglucose F18/*metabolism , Lung Neoplasms/*drug therapy , Positron-Emission Tomography/*methods , Proto-Oncogene Proteins p21(ras)/*metabolism , Sorafenib/*therapeutic use, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Everolimus/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Sorafenib/pharmacology

المؤلفون: Scheffler M; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Holzem A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Kron A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Nogova L; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Ihle MA; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., von Levetzow C; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Fassunke J; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Wömpner C; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Bitter E; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Koleczko S; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Abdulla DSY; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Michels S; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Fischer R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Riedel R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Weber JP; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Westphal T; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Gerigk U; GFO Clinics Bonn, Marien-Hospital Bonn, Bonn, Germany., Kern J; KWM Missio Clinic, Würzburg, Germany., Kaminsky B; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany., Randerath W; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany., Kambartel KO; Bethanien Hospital Moers, Lung Center, Moers, Germany., Merkelbach-Bruse S; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Büttner R; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Wolf J; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Jun; Vol. 144, pp. 40-48. Date of Electronic Publication: 2020 Apr 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Kelch-Like ECH-Associated Protein 1 ; MAP Kinase Kinase 1/genetics ; Mutation ; NF-E2-Related Factor 2 ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics

المؤلفون: Riedel R; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Michels S; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Heydt C; Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Siemanowski J; Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Kobe C; Department for Nuclear Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Bunck A; Department for Radiology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Schäfer S; Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Fischer RN; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Scheffler M; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Abdulla DSY; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Nogová L; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Koleczko S; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany., Merkelbach-Bruse S; Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Büttner R; Institute of Pathology, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany., Wolf J; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2019 Jul; Vol. 133, pp. 20-22. Date of Electronic Publication: 2019 May 06.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma of Lung/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Crizotinib/*therapeutic use , Lung Neoplasms/*drug therapy , Mutation/*genetics , Proto-Oncogene Proteins c-met/*genetics , Proto-Oncogene Proteins p21(ras)/*genetics, Adenocarcinoma of Lung/genetics ; Biomarkers, Tumor/genetics ; Carcinogenesis/genetics ; Drug Resistance, Neoplasm/genetics ; Female ; Gene Amplification ; Humans ; Lung Neoplasms/genetics ; Middle Aged ; Proto-Oncogene Proteins c-met/antagonists & inhibitors ; Proto-Oncogene Proteins p21(ras)/antagonists & inhibitors

المؤلفون: Michels S; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Massutí B; Department of Oncology, Alicante University Hospital-ISABIAL, Alicante, Spain., Schildhaus HU; Institute of Pathology, University Hospital Goettingen, Göttingen, Germany and Targos Molecular Pathology, Kassel, Germany., Franklin J; Institute of Medical Statistics and Computational Biology, University Hospital Cologne, Cologne, Germany., Sebastian M; Department of Hematology and Oncology, University Hospital of Frankfurt, Frankfurt am Main, Germany., Felip E; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Grohé C; Department of Pneumology, Protestant Lung Hospital Berlin, Berlin, Germany., Rodriguez-Abreu D; Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain., Abdulla DSY; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Bischoff H; Thoraxonkologie, Thoraxklinik, Heidelberg, Germany., Brandts C; Department of Hematology and Oncology, University Hospital of Frankfurt, Frankfurt am Main, Germany., Carcereny E; Servei d'Oncologia Mèdica, Institut Català d'Oncologia Badalona-Hospital Germans Trias i Pujol, Carretera de Canyet, Badalona, Spain., Corral J; Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain; prior affiliation during the trial: Hospital Universitario Virgen del Rocío, Sevilla, Spain., Dingemans AC; Department for Oncology, Maastricht University Medical Center, Maastricht, Netherlands., Pereira E; Spanish Lung Cancer Group, Barcelona, Spain., Fassunke J; Lung Cancer Group Cologne, Institute of Pathology and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Fischer RN; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Gardizi M; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Heukamp L; Institute of Hematopatholgy Hamburg, Hamburg, Germany, and Lung Cancer Network NOWEL, Oldenburg, Germany., Insa A; Hospital Clínico Universitario de Valencia, València, Spain., Kron A; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Menon R; NEO New Oncology GmbH, Cologne, Germany., Persigehl T; Department of Radiology, University Hospital Cologne, Cologne, Germany., Reck M; Department for Thoracic Oncology, Airway Research Center North (ARCN), German Center for Lung Research, LungenClinic Grosshansdorf, Großhansdorf, Germany., Riedel R; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Rothschild SI; University Hospital Basel, Department Internal Medicine, Medical Oncology, Basel, Switzerland., Scheel AH; Lung Cancer Group Cologne, Institute of Pathology and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Scheffler M; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Schmalz P; Clinical Trials Centre Cologne (CTCC) Medical Faculty, University of Cologne, Cologne, Germany., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Limburg M; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Spain., Karachaliou N; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain; Institute of Oncology Rosell (IOR), University Hospital Sagrat Cor, Barcelona, Spain., Merkelbach-Bruse S; Lung Cancer Group Cologne, Institute of Pathology and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Hellmich M; Institute of Medical Statistics and Computational Biology, University Hospital Cologne, Cologne, Germany., Nogova L; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Büttner R; Lung Cancer Group Cologne, Institute of Pathology and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany., Rosell R; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain; Institute of Oncology Rosell (IOR), University Hospital Sagrat Cor, Barcelona, Spain; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain., Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2019 Jul; Vol. 14 (7), pp. 1266-1276. Date of Electronic Publication: 2019 Apr 09.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gene Rearrangement*, Brain Neoplasms/*drug therapy , Carcinoma, Non-Small-Cell Lung/*drug therapy , Crizotinib/*therapeutic use , Lung Neoplasms/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , Protein-Tyrosine Kinases/*genetics , Proto-Oncogene Proteins/*genetics, Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/genetics ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Response Evaluation Criteria in Solid Tumors ; Survival Rate

المؤلفون: Scheffler M; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Ihle MA; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Hein R; University of Cologne, Institute of Medical Statistics, Informatics and Epidemiology, Cologne, Germany., Merkelbach-Bruse S; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Scheel AH; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Siemanowski J; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Brägelmann J; University of Cologne, Department for Translational Genomics, Cologne, Germany., Kron A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Abedpour N; University of Cologne, Department for Translational Genomics, Cologne, Germany., Ueckeroth F; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Schüller M; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Koleczko S; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Michels S; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Fassunke J; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Pasternack H; Pathology of the University Medical Center Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Center for Medicine and Biosciences., Heydt C; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Serke M; Lung Clinic Hemer, Department for Pulmonology and Thoracic Oncology, Hemer, Germany., Fischer R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Schulte W; GFO Clinics Bonn, Marien-Hospital Bonn, Bonn, Germany., Gerigk U; GFO Clinics Bonn, Marien-Hospital Bonn, Bonn, Germany., Nogova L; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Ko YD; Evangelical Clinics of Bonn, Johanniter Hospital, Bonn, Germany., Abdulla DSY; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Riedel R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Kambartel KO; Bethanien Hospital Moers, Lung Center, Moers, Germany., Lorenz J; Hospital Lüdenscheid, Clinic for Pneumology, Internistic Intensive Medicine, Infectiology and Sleep Medicine, Lüdenscheid, Germany., Sauerland I; Hospital Lüdenscheid, Clinic for Pneumology, Internistic Intensive Medicine, Infectiology and Sleep Medicine, Lüdenscheid, Germany., Randerath W; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany., Kaminsky B; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany., Hagmeyer L; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany., Grohé C; Evangelic Lung Clinic Berlin, Department of Respiratory Diseases, Berlin, Germany., Eisert A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Frank R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Gogl L; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Schaepers C; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Holzem A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany., Hellmich M; University of Cologne, Institute of Medical Statistics, Informatics and Epidemiology, Cologne, Germany., Thomas RK; University of Cologne, Department for Translational Genomics, Cologne, Germany., Peifer M; University of Cologne, Department for Translational Genomics, Cologne, Germany., Sos ML; University of Cologne, Department for Translational Genomics, Cologne, Germany., Büttner R; University of Cologne, Cologne Institute of Pathology, Cologne, Germany., Wolf J; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2019 Apr; Vol. 14 (4), pp. 606-616. Date of Electronic Publication: 2018 Dec 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*genetics , Lung Neoplasms/*genetics , Proto-Oncogene Proteins p21(ras)/*genetics, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/enzymology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Mutation

المؤلفون: Abdulla DSY; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Scheffler M; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Brandes V; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Ruge M; Center for Integrated Oncology Köln, Bonn, Germany; Department of Stereotaxy and Functional Neurosurgery, University Hospital of Cologne, Cologne, Germany., Kunze S; Center for Integrated Oncology Köln, Bonn, Germany; Department of Radiotherapy, University Hospital of Cologne, Cologne, Germany., Merkelbach-Bruse S; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany; Department of Pathology, University Hospital of Cologne, Cologne, Germany., Nogova L; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Michels S; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Fischer R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Riedel R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany., Büttner R; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany; Department of Pathology, University Hospital of Cologne, Cologne, Germany., Persigehl T; Center for Integrated Oncology Köln, Bonn, Germany; Department of Radiology, University Hospital of Cologne, Cologne, Germany., Grau S; Center for Integrated Oncology Köln, Bonn, Germany; Department of Neurosurgery, University Hospital of Cologne, Cologne, Germany., Galldiks N; Center for Integrated Oncology Köln, Bonn, Germany; Department of Neurology, University Hospital of Cologne, Cologne, Germany; Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany., Drzezga A; Center for Integrated Oncology Köln, Bonn, Germany; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany., Kobe C; Center for Integrated Oncology Köln, Bonn, Germany; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany., Wolf J; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2019 Mar; Vol. 20 (2), pp. e148-e151. Date of Electronic Publication: 2018 Nov 05.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Brain Neoplasms/*diagnosis , Carcinoma, Non-Small-Cell Lung/*diagnosis , Erlotinib Hydrochloride/*therapeutic use , Lung Neoplasms/*diagnosis , Tyrosine/*analogs & derivatives, Adult ; Brain Neoplasms/drug therapy ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/secondary ; ErbB Receptors/genetics ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Mutation/genetics ; Positron-Emission Tomography